Arcus Biosciences Files 8-K: Other Events & Exhibits
Ticker: RCUS · Form: 8-K · Filed: Feb 19, 2025 · CIK: 1724521
Sentiment: neutral
Topics: 8-k, filing, exhibits
TL;DR
Arcus Biosciences filed an 8-K on Feb 19, 2025, reporting 'Other Events' and exhibits.
AI Summary
Arcus Biosciences, Inc. filed an 8-K on February 19, 2025, reporting other events and financial statements/exhibits. The filing date is February 19, 2025, with the earliest event reported on February 18, 2025. The company is incorporated in Delaware and its principal executive offices are located in Hayward, California.
Why It Matters
This 8-K filing indicates that Arcus Biosciences is disclosing material information beyond routine updates, potentially related to significant business events or financial reporting.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for reporting events and exhibits, not indicating any immediate financial distress or significant negative news.
Key Numbers
- 001-38419 — SEC File Number (Identifies the company's filing with the SEC.)
- 47-3898435 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Arcus Biosciences, Inc. (company) — Registrant
- February 18, 2025 (date) — Earliest event reported
- February 19, 2025 (date) — Date of report and filing
- Delaware (jurisdiction) — State of incorporation
- Hayward, California (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Arcus Biosciences in this 8-K?
The provided text does not detail the specific 'Other Events' beyond stating that this item is being reported.
What is the significance of filing 'Financial Statements and Exhibits' on an 8-K?
Filing financial statements and exhibits on an 8-K typically accompanies significant corporate events or provides updated financial information as required by the SEC.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on February 18, 2025.
Where are Arcus Biosciences' principal executive offices located?
Arcus Biosciences' principal executive offices are located at 3928 Point Eden Way, Hayward, California, 94545.
What is the company's SEC file number?
The company's SEC file number is 001-38419.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding Arcus Biosciences, Inc. (RCUS).